VIAP
Price:
$0.0005
Market Cap:
$10.28K
VIA Pharmaceuticals, Inc. is an emerging biotechnology company primarily focused on discovering and advancing therapeutic compounds for cardiovascular and metabolic disorders. The firm is building a portfolio of small-molecule drug candidates designed to tackle the root causes of these health issues, such as vascular inflammation, elevated cholesterol and triglyceride levels, and insulin resistance or diabetes. Notable candidates in their development pipeline include: VIA-3196: A liver-specific thyroid hormone receptor (THR) beta agonist, poised for Phase 1 clinical studies. This drug aims to mitigate dyslipidemia, addressing high LDL cholesterol, elevated triglycerides, and Lp(a) levels. A ...[Read more]
Industry
Medical - Pharmaceuticals
IPO Date
2007-06-06
Stock Exchange
OTC
Ticker
VIAP
According to VIA Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 13.93M. This represents a change of -2.09% compared to the average of 14.22M of the last 4 quarters.
The mean historical Enterprise Value of VIA Pharmaceuticals, Inc. over the last ten years is 33.04M. The current 13.93M Enterprise Value has changed 4.12% with respect to the historical average. Over the past ten years (40 quarters), VIAP's Enterprise Value was at its highest in in the June 2001 quarter at 166.18M. The Enterprise Value was at its lowest in in the December 2008 quarter at -527377.29.
Average
33.04M
Median
24.22M
Minimum
-537330.97
Maximum
85.01M
Discovering the peaks and valleys of VIA Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 369.51%
Maximum Annual Enterprise Value = 85.01M
Minimum Annual Increase = -2294.90%
Minimum Annual Enterprise Value = -537330.97
| Year | Enterprise Value | Change |
|---|---|---|
| 2010 | 14.74M | 24.94% |
| 2009 | 11.79M | -2294.90% |
| 2008 | -537330.97 | -172.96% |
| 2007 | 736.45K | -97.81% |
| 2006 | 33.70M | -60.36% |
| 2005 | 85.01M | 3.05% |
| 2004 | 82.50M | 115.46% |
| 2003 | 38.29M | 369.51% |
| 2002 | 8.16M | -85.44% |
| 2001 | 56.01M | -69.24% |
The current Enterprise Value of VIA Pharmaceuticals, Inc. (VIAP) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
8.66M
5-year avg
12.08M
10-year avg
33.04M
VIA Pharmaceuticals, Inc.’s Enterprise Value is less than Arcturus Therapeutics Holdings Inc. (305.35M), greater than ARYx Therapeutics, Inc. (4.43M), greater than MultiCell Technologies, Inc. (5.09K), greater than Neurobiological Technologies, Inc. (-1839298.00), greater than Panacos Pharmaceuticals, Inc. (-18548633.00), greater than Poniard Pharmaceuticals, Inc. (290.15K),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 305.35M | $473.90M | |
| 4.43M | $16.73K | |
| 5.09K | $5.00K | |
| -1839298.00 | $2.70K | |
| -18548633.00 | $5.37K | |
| 290.15K | $150.00 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like VIA Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like VIA Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is VIA Pharmaceuticals, Inc.'s Enterprise Value?
What is the highest Enterprise Value for VIA Pharmaceuticals, Inc. (VIAP)?
What is the 3-year average Enterprise Value for VIA Pharmaceuticals, Inc. (VIAP)?
What is the 5-year average Enterprise Value for VIA Pharmaceuticals, Inc. (VIAP)?
How does the current Enterprise Value for VIA Pharmaceuticals, Inc. (VIAP) compare to its historical average?